Process for depigmenting keratin materials using thiopyridinone compounds
Abstract
The invention relates to a cosmetic process for depigmenting, lightening and/or whitening keratin materials, in particular the skin, which comprises the application of a cosmetic composition comprising a compound of formula (I):or its tautomer form of formula (I′):in which:R1 and R2, which may be identical or different, denote a radical chosen from:a) a hydrogen atom;b) a C1-C20 alkyl group optionally interrupted with N, S or O, optionally substituted with one or more group(s) chosen from -—OR3, —SR3, —NR3R4, —CONHR3; —COORS; and an aryl group optionally substituted with one or more hydroxyls and/or with one or more C1-C8 alkoxy radicals;c) a C1-C8 alkyl group substituted with a C5-C12 aryl radical optionally substituted with one or more hydroxyls and/or with one or more C1-C8 alkoxy radicals;d) a phenyl group optionally substituted with one or more hydroxyls and/or with one or more C1-C8 alkoxy radicals;R3 denoting H or a C1-C5 alkyl group,R4 denoting H, a C1-C5 hydrocarbon-based group or an acetyl group;it being possible for R1 and R2 to form, with the nitrogen atom which bears them, a ring chosen from pyrrolidine, pyrroline, piperidine, piperazine, morpholine, thiomorpholine and azepine.The invention also relates to the cosmetic use of a compound (I) or (I′) as a whitening, lightening and/or depigmenting agent for keratin materials.
Claims
exact text as granted — not AI-modified1 . Nontherapeutic cosmetic process for depigmenting, lightening and/or whitening keratin materials, which comprises the application of a cosmetic composition comprising, in a physiologically acceptable medium, at least one compound of formula (I):
or its tautomer form of formula (I′):
in which:
R 1 and R 2 , which may be identical or different, denote a radical chosen from:
a) a hydrogen atom;
b) a saturated linear C 1 -C 20 or branched C 3 -C 20 or unsaturated C 2 -C 20 alkyl group, optionally interrupted with one or more heteroatoms chosen from N, S and O, and/or optionally substituted with one or more groups, which may be identical or different, chosen from:
i) —OR 3
ii) —SR 3 ,
iii) —NR 3 R 4
iv) —CONHR 3
v) —COOR 3 ;
vi) a C 5 -C 12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C 1 -C 8 alkoxy radicals;
c) a saturated C 1 -C 8 alkyl group substituted with a C 5 -C 12 aryl radical optionally substituted with one or more hydroxyls and/or with one or more C 1 -C 8 alkoxy radicals;
d) a phenyl group optionally substituted with one or more hydroxyls and/or with one or more C 1 -C 8 alkoxy radicals;
R 3 denoting a hydrogen atom or a saturated linear C 1 -C 5 or branched C 3 -C 5 or unsaturated C 2 -C 5 hydrocarbon-based group,
R 4 denoting a hydrogen atom; a saturated linear C 1 -C 5 or branched C 3 -C 5 hydrocarbon-based group; or an acetyl group;
it being possible for R 1 and R 2 to form, with the nitrogen atom which bears them, a ring chosen from pyrrolidine, pyrroline, piperidine, piperazine, morpholine, thiomorpholine and azepine;
and also the salts thereof, the optical isomers thereof and the racemates thereof.Join the waitlist — get patent alerts
Track US2021401709A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.